X-103609183-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032926.3(TCEAL3):c.119G>A(p.Gly40Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000512 in 1,210,095 control chromosomes in the GnomAD database, including 1 homozygotes. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032926.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCEAL3 | ENST00000372627.10 | c.119G>A | p.Gly40Glu | missense_variant | Exon 3 of 3 | 1 | NM_032926.3 | ENSP00000361710.5 | ||
TCEAL3 | ENST00000243286.7 | c.119G>A | p.Gly40Glu | missense_variant | Exon 3 of 3 | 1 | ENSP00000243286.3 | |||
TCEAL3 | ENST00000372628.5 | c.119G>A | p.Gly40Glu | missense_variant | Exon 3 of 3 | 5 | ENSP00000361711.1 | |||
TCEAL3 | ENST00000477014.1 | n.158+510G>A | intron_variant | Intron 2 of 6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000626 AC: 7AN: 111856Hom.: 1 Cov.: 24 AF XY: 0.0000588 AC XY: 2AN XY: 33994
GnomAD3 exomes AF: 0.000284 AC: 52AN: 183302Hom.: 0 AF XY: 0.000148 AC XY: 10AN XY: 67764
GnomAD4 exome AF: 0.0000501 AC: 55AN: 1098239Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 10AN XY: 363595
GnomAD4 genome AF: 0.0000626 AC: 7AN: 111856Hom.: 1 Cov.: 24 AF XY: 0.0000588 AC XY: 2AN XY: 33994
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.119G>A (p.G40E) alteration is located in exon 3 (coding exon 1) of the TCEAL3 gene. This alteration results from a G to A substitution at nucleotide position 119, causing the glycine (G) at amino acid position 40 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at